Sign in
Not yet recruitingPhase 4

BETARGET : Randomized trial of individualizing BETA-lactam taRGET combining therapeutic drug monitoring, minimal inhibitory concentration and model-based dose adjustment, in Intensive Care Units patients with gram negative bacilli infection

Key facts

Who runs it
Centre Hospitalier Universitaire De Rennes
Where
France19 sites in 1 countryChoose a country to see its sites
Status
Not yet recruiting
Phase
Phase 4
People taking part
672 people, planned
Started
1 Sept 2026
Expected to end
1 Feb 2029
Type of study
Interventional
Record updated
6 August 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Age ≥ 18 years
  • Hospitalization in ICU
  • Sepsis
  • Enterobacterales or non-fermenting Gram negative bacilli microbiological documentation
  • Beta-lactam antibiotic therapy with CEFOTAXIME, CEFTAZIDIME, CEFEPIME, PIPERACILLINE, PIPERACILLINE-TAZOBACTAM, MEROPENEME, AMOXICILLINE, CEFTAZIDIME-AVIBACTAM
  • Information of the patient or a relative/legal representative, or use of the emergency procedure

Who cannot take part

  • Allergy to beta-lactams
  • Urinary infection
  • Plurimicrobial infection
  • “Complex” infection: central nervous system infection, bone or joint infection
  • Protected person (adults legally protected (under judicial protection, guardianship or supervision), person deprived of their liberty, pregnant woman, lactating woman and minor)
  • Impossibility to measure the MIC of the defined bacteria
  • Absence of coverage by a social security scheme

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Evaluate the impact of an individualized strategy (BETARGET strategy including MIC, TDM and model-based adjustement) for beta-lactam therapy in ICU NGB-infected patients on the ICU free days at day 28.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Record updated
6 August 2026